UniProt ID | DDX23_HUMAN | |
---|---|---|
UniProt AC | Q9BUQ8 | |
Protein Name | Probable ATP-dependent RNA helicase DDX23 | |
Gene Name | DDX23 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 820 | |
Subcellular Localization | Nucleus . | |
Protein Description | Involved in pre-mRNA splicing and its phosphorylated form (by SRPK2) is required for spliceosomal B complex formation.. | |
Protein Sequence | MAGELADKKDRDASPSKEERKRSRTPDRERDRDRDRKSSPSKDRKRHRSRDRRRGGSRSRSRSRSKSAERERRHKERERDKERDRNKKDRDRDKDGHRRDKDRKRSSLSPGRGKDFKSRKDRDSKKDEEDEHGDKKPKAQPLSLEELLAKKKAEEEAEAKPKFLSKAEREAEALKRRQQEVEERQRMLEEERKKRKQFQDLGRKMLEDPQERERRERRERMERETNGNEDEEGRQKIREEKDKSKELHAIKERYLGGIKKRRRTRHLNDRKFVFEWDASEDTSIDYNPLYKERHQVQLLGRGFIAGIDLKQQKREQSRFYGDLMEKRRTLEEKEQEEARLRKLRKKEAKQRWDDRHWSQKKLDEMTDRDWRIFREDYSITTKGGKIPNPIRSWKDSSLPPHILEVIDKCGYKEPTPIQRQAIPIGLQNRDIIGVAETGSGKTAAFLIPLLVWITTLPKIDRIEESDQGPYAIILAPTRELAQQIEEETIKFGKPLGIRTVAVIGGISREDQGFRLRMGCEIVIATPGRLIDVLENRYLVLSRCTYVVLDEADRMIDMGFEPDVQKILEHMPVSNQKPDTDEAEDPEKMLANFESGKHKYRQTVMFTATMPPAVERLARSYLRRPAVVYIGSAGKPHERVEQKVFLMSESEKRKKLLAILEQGFDPPIIIFVNQKKGCDVLAKSLEKMGYNACTLHGGKGQEQREFALSNLKAGAKDILVATDVAGRGIDIQDVSMVVNYDMAKNIEDYIHRIGRTGRAGKSGVAITFLTKEDSAVFYELKQAILESPVSSCPPELANHPDAQHKPGTILTKKRREETIFA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | Phosphorylation | DKKDRDASPSKEERK CCCCCCCCCCHHHHH | 33.71 | 29255136 | |
16 | Phosphorylation | KDRDASPSKEERKRS CCCCCCCCHHHHHHH | 50.64 | 30266825 | |
23 | Phosphorylation | SKEERKRSRTPDRER CHHHHHHHCCCCHHH | 43.47 | 20068231 | |
25 | Phosphorylation | EERKRSRTPDRERDR HHHHHHCCCCHHHHH | 30.68 | 20068231 | |
38 | Phosphorylation | DRDRDRKSSPSKDRK HHHCCCCCCCCHHHH | 48.66 | 22210691 | |
39 | Phosphorylation | RDRDRKSSPSKDRKR HHCCCCCCCCHHHHH | 35.91 | 27422710 | |
41 | Phosphorylation | RDRKSSPSKDRKRHR CCCCCCCCHHHHHHH | 49.49 | 26074081 | |
67 | Phosphorylation | RSRSRSKSAERERRH HHHHHHHHHHHHHHH | 36.29 | 22817900 | |
106 | Phosphorylation | RDKDRKRSSLSPGRG CHHHHCHHCCCCCCC | 38.37 | 22167270 | |
107 | Phosphorylation | DKDRKRSSLSPGRGK HHHHCHHCCCCCCCC | 36.58 | 22167270 | |
109 | Phosphorylation | DRKRSSLSPGRGKDF HHCHHCCCCCCCCCC | 27.53 | 22167270 | |
124 | Phosphorylation | KSRKDRDSKKDEEDE CCCCCCCCCCCCCCC | 42.36 | 30576142 | |
136 | Acetylation | EDEHGDKKPKAQPLS CCCCCCCCCCCCCCC | 57.39 | 30588055 | |
138 | Acetylation | EHGDKKPKAQPLSLE CCCCCCCCCCCCCHH | 69.41 | 30588061 | |
143 | Phosphorylation | KPKAQPLSLEELLAK CCCCCCCCHHHHHHH | 40.18 | 25849741 | |
150 | Acetylation | SLEELLAKKKAEEEA CHHHHHHHHHHHHHH | 55.57 | 30588067 | |
150 | 2-Hydroxyisobutyrylation | SLEELLAKKKAEEEA CHHHHHHHHHHHHHH | 55.57 | - | |
150 | Ubiquitination | SLEELLAKKKAEEEA CHHHHHHHHHHHHHH | 55.57 | - | |
160 | Acetylation | AEEEAEAKPKFLSKA HHHHHHHCHHHHHHH | 40.00 | 26051181 | |
166 | 2-Hydroxyisobutyrylation | AKPKFLSKAEREAEA HCHHHHHHHHHHHHH | 57.31 | - | |
196 | Malonylation | EEERKKRKQFQDLGR HHHHHHHHHHHHHHH | 65.43 | 26320211 | |
205 | Sulfoxidation | FQDLGRKMLEDPQER HHHHHHHHCCCHHHH | 4.83 | 21406390 | |
251 | Ubiquitination | SKELHAIKERYLGGI HHHHHHHHHHHHCCH | 36.60 | - | |
259 | 2-Hydroxyisobutyrylation | ERYLGGIKKRRRTRH HHHHCCHHHHCCCCC | 43.43 | - | |
264 | Phosphorylation | GIKKRRRTRHLNDRK CHHHHCCCCCCCCCC | 22.19 | - | |
301 | Methylation | HQVQLLGRGFIAGID HHHHHHCCCEECCCC | 36.50 | - | |
310 | 2-Hydroxyisobutyrylation | FIAGIDLKQQKREQS EECCCCHHHHHHHHH | 47.11 | - | |
326 | 2-Hydroxyisobutyrylation | FYGDLMEKRRTLEEK HHHHHHHHHHCHHHH | 32.96 | - | |
326 | Ubiquitination | FYGDLMEKRRTLEEK HHHHHHHHHHCHHHH | 32.96 | 21890473 | |
326 | Ubiquitination | FYGDLMEKRRTLEEK HHHHHHHHHHCHHHH | 32.96 | 21890473 | |
333 | Acetylation | KRRTLEEKEQEEARL HHHCHHHHHHHHHHH | 56.15 | 26051181 | |
366 | Phosphorylation | QKKLDEMTDRDWRIF HHHHHHCCCCCHHHH | 26.32 | 26074081 | |
377 | Phosphorylation | WRIFREDYSITTKGG HHHHHCCCEEEECCC | 9.38 | - | |
378 | Phosphorylation | RIFREDYSITTKGGK HHHHCCCEEEECCCC | 26.27 | - | |
380 | Phosphorylation | FREDYSITTKGGKIP HHCCCEEEECCCCCC | 19.26 | - | |
381 | Phosphorylation | REDYSITTKGGKIPN HCCCEEEECCCCCCC | 26.48 | - | |
394 | Acetylation | PNPIRSWKDSSLPPH CCCCCCCCCCCCCHH | 49.32 | 26051181 | |
412 | Acetylation | VIDKCGYKEPTPIQR HHHHCCCCCCCCCCC | 42.36 | 25953088 | |
437 | Phosphorylation | DIIGVAETGSGKTAA CEEEEEECCCCHHHH | 27.23 | 21406692 | |
439 | Phosphorylation | IGVAETGSGKTAAFL EEEEECCCCHHHHHH | 44.53 | 21406692 | |
470 | Phosphorylation | EESDQGPYAIILAPT CCCCCCCEEEEEECH | 19.77 | - | |
477 | Phosphorylation | YAIILAPTRELAQQI EEEEEECHHHHHHHH | 31.04 | - | |
490 | Acetylation | QIEEETIKFGKPLGI HHHHHHHHCCCCCCC | 56.32 | 25953088 | |
507 | Phosphorylation | VAVIGGISREDQGFR EEEECCCCHHHCCCE | 32.65 | 20068231 | |
508 | Dimethylation | AVIGGISREDQGFRL EEECCCCHHHCCCEE | 49.98 | - | |
517 | Sulfoxidation | DQGFRLRMGCEIVIA HCCCEEECCCEEEEE | 9.48 | 21406390 | |
541 | Phosphorylation | ENRYLVLSRCTYVVL CCCHHHEECCCEEEE | 20.17 | 24719451 | |
545 | Phosphorylation | LVLSRCTYVVLDEAD HHEECCCEEEEECHH | 7.68 | 28787133 | |
579 | Phosphorylation | VSNQKPDTDEAEDPE CCCCCCCCCCCCCHH | 44.24 | - | |
602 | Phosphorylation | GKHKYRQTVMFTATM CCCCEEEEEEEECCC | 12.63 | 23403867 | |
606 | Phosphorylation | YRQTVMFTATMPPAV EEEEEEEECCCCHHH | 11.79 | 23403867 | |
608 | Phosphorylation | QTVMFTATMPPAVER EEEEEECCCCHHHHH | 27.44 | 23403867 | |
619 | Phosphorylation | AVERLARSYLRRPAV HHHHHHHHHHCCCEE | 23.94 | 23917254 | |
620 | Phosphorylation | VERLARSYLRRPAVV HHHHHHHHHCCCEEE | 9.93 | 22817900 | |
628 | Phosphorylation | LRRPAVVYIGSAGKP HCCCEEEEECCCCCC | 7.93 | 28152594 | |
631 | Phosphorylation | PAVVYIGSAGKPHER CEEEEECCCCCCHHH | 25.04 | 28152594 | |
634 | Acetylation | VYIGSAGKPHERVEQ EEECCCCCCHHHHHH | 42.81 | 26051181 | |
642 | Acetylation | PHERVEQKVFLMSES CHHHHHHHEEECCHH | 22.81 | 132847 | |
647 | Phosphorylation | EQKVFLMSESEKRKK HHHEEECCHHHHHHH | 39.87 | - | |
651 | 2-Hydroxyisobutyrylation | FLMSESEKRKKLLAI EECCHHHHHHHHHHH | 77.97 | - | |
682 | Acetylation | KGCDVLAKSLEKMGY CCHHHHHHHHHHCCC | 51.95 | 25953088 | |
686 | Acetylation | VLAKSLEKMGYNACT HHHHHHHHCCCCEEE | 42.81 | 25953088 | |
686 | Sumoylation | VLAKSLEKMGYNACT HHHHHHHHCCCCEEE | 42.81 | 28112733 | |
686 | Ubiquitination | VLAKSLEKMGYNACT HHHHHHHHCCCCEEE | 42.81 | - | |
698 | Ubiquitination | ACTLHGGKGQEQREF EEECCCCCCHHHHHH | 63.11 | - | |
698 | Acetylation | ACTLHGGKGQEQREF EEECCCCCCHHHHHH | 63.11 | 26051181 | |
711 | Ubiquitination | EFALSNLKAGAKDIL HHHHHHHHCCCCEEE | 49.37 | - | |
715 | Malonylation | SNLKAGAKDILVATD HHHHCCCCEEEEEEC | 44.37 | 26320211 | |
715 | Acetylation | SNLKAGAKDILVATD HHHHCCCCEEEEEEC | 44.37 | 23749302 | |
715 | 2-Hydroxyisobutyrylation | SNLKAGAKDILVATD HHHHCCCCEEEEEEC | 44.37 | - | |
748 | Phosphorylation | MAKNIEDYIHRIGRT HHCCHHHHHHHHCCC | 5.95 | - | |
755 | Phosphorylation | YIHRIGRTGRAGKSG HHHHHCCCCCCCCCC | 26.30 | - | |
761 | Phosphorylation | RTGRAGKSGVAITFL CCCCCCCCCEEEEEE | 37.27 | 21712546 | |
777 | Phosphorylation | KEDSAVFYELKQAIL CCCCHHHHHHHHHHH | 17.47 | 28152594 | |
790 | Phosphorylation | ILESPVSSCPPELAN HHHCCHHCCCHHHHC | 30.77 | - | |
804 | Acetylation | NHPDAQHKPGTILTK CCCCCCCCCCCCCCC | 32.82 | 26051181 | |
807 | Phosphorylation | DAQHKPGTILTKKRR CCCCCCCCCCCCCCC | 22.72 | - | |
811 | Sumoylation | KPGTILTKKRREETI CCCCCCCCCCCHHCC | 40.62 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DDX23_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DDX23_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DDX23_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107 AND SER-109, ANDMASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; THR-25; SER-107 ANDSER-109, AND MASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. |